Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study

BACKGROUND: Transarterial chemoembolization (TACE) and sorafenib (SOR) are well-established treatments for hepatocellular carcinoma (HCC). This study evaluates the efficacy and safety of SOR combined with TACE in the treatment of patients with TACE-refractory, advanced-stage HCC. METHODS: This retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jianbing, Li, An, Yang, Jiajin, Lu, Yanjun, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457121/
https://www.ncbi.nlm.nih.gov/pubmed/28603426
http://dx.doi.org/10.2147/OTT.S131022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457121/
https://www.ncbi.nlm.nih.gov/pubmed/28603426
http://dx.doi.org/10.2147/OTT.S131022

Ejemplares similares